Lensar jumps on quarterly revenue beat

LENSAR

27/02/2025 19:18

** Shares of medtech firm Lensar LNSR.O rise 28.8% to $12.20 in afternoon trade

** Company posts Q4 revenue of $16.7 million, benefiting from its cataract surgery tech system, ALLY, beating analysts' estimates of $14.90 million, according to data compiled by LSEG

** Company posts Q4 net loss of $1.61 per share, vs estimates of 18 cents

** Expects Q1 revenue growth to align with 2024 rate

** In the past 12 months, LNSR up 94%

 (Reporting by Siddhi Mahatole)

 ((Siddhiprabhanjan.mahatole@thomsonreuters.com))